Skip to content

PRE.C.I.S.A - Fall Prevention and Promotion of Active and Healthy Aging

Efficacy of a Multifactorial and Personalized Program for Fall Prevention in Community-dwelling Elderly in Comparison to the Usual Care: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03592420
Acronym
PRECISA
Enrollment
366
Registered
2018-07-19
Start date
2014-12-31
Completion date
2017-06-30
Last updated
2018-07-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Fall, Parkinson Disease, Stroke

Keywords

Accidental falls, Clinical trial, Aged, Parkinson's Disease, Stroke, Exercise, Education

Brief summary

Randomized Controlled Trial (RCT) aiming at assessing the efficacy of an interdisciplinary multi-component and personalized multi-factorial intervention for reducing falls at one year post-enrolment in comparison to the usual care in a sample of community dwelling elderly (age ≥65 years), with or without Parkinson's Disease and/or previous Stroke.

Detailed description

BACKGROUND: Current literature on fall prevention for community-dwelling elderly who are at risk of falling suggests that: 1) either single, multicomponent or multifactorial interventions are effective at preventing falls; 2) elderly at risk of falling with Parkinson's Disease (PD) and previous Stroke, although having an even greater risk of falling, are often excluded by these interventions; 3) often, present screening methods for risk of falling do not allow the early identification of subjects at risk before the first fall. AIMS * To compare the efficacy of an interdisciplinary multicomponent and personalized multifactorial intervention aiming at reducing falls in comparison to the usual care, in a sample of community dwelling elderly, with or without Parkinson's Disease and/or previous Stroke, within the context of an RCT. * To improve the accuracy of screening tests for risk of falling by using wearable inertial sensors. * To develop a reduced set of clinical and instrumental indicators, to be utilized as a quick and reliable screening tests in outpatients clinics. METHODS: multicenter, randomized controller trial, with blind assessments on pretest, postest and on one-year follow-up. POPULATION: community-dwelling elderly (aged ≥65 years) with age-related or neurological condition-related (Parkinson's Disease and/or Stroke) risk of falling. INTERVENTION: interdisciplinary multi-component (group-based exercise; home-based exercise; increasing knowledge/education; home safety interventions) and personalized multi-factorial interventions (assessment and treatment of individual fall risk factors) CONTROL: structured information about participant's own personal risk factors given to the family doctor. OUTCOMES: The primary endpoint is the fall rate at one year in both groups. The secondary endpoint is the fall risk at one year. EXPECTED RESULTS: in the intervention group, a significant reduction in the number of total fall is expected, together with decreases indicators of utilization of acute health services because of falls. At three months, it is expected a significant improvement of functioning (motor functions, activity and participation) and health quality indicators.

Interventions

BEHAVIORALInterdisciplinary multicomponent interventions
BEHAVIORALUsual care

standard care

Sponsors

Azienda Ospedaliero-Universitaria di Modena
CollaboratorOTHER
Azienda USL Reggio Emilia - IRCCS
CollaboratorOTHER_GOV
Azienda Unita' Sanitaria Locale Di Modena
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Community-dwelling elderly (aged ≥65 years) 2. Moderate to high fall risk, either associated to aging or to neurological diseases as Parkinson's Disease and stroke. 3. Ability to walk 10 meters without assistance (walking aid permitted) 4. Informed consent to participation

Exclusion criteria

1. Whatever concurrent medical condition which may constitutes a contraindication to physical exercise 2. Known cognitive decline or an established diagnosis of dementia (mini mental score \>24) or an evident cognitive decline on pre-enrolment which would be likely to impair the ability of comprehension of simple instructions and / or of collaborating 3. Severe hearing impairment, so that a subject will not understand less than 80% of ordinary conversation with/or without hearing aids. 4. Severe hypovision, not counteracted by lenses, which will limit the patient in executing at least one activity of daily living (for instance, necessity of assistance for walking because of visual deficit). 5. Severe aphasia or visuo-spatial deficits, to the extent that these impairments will limit significantly the ability to comprehend (orally or visually) simple instructions. 6. Acute vertigo or dizziness lasting less than 3 months 7. Regular participation to other exercise program that it is likely to challenge balance, including physical therapy.

Design outcomes

Primary

MeasureTime frameDescription
Fall rate at 12 months from enrolmentMonths 1 - Months 12The primary endpoint will be the total number of falls (fall rate) occurred in each arm within 12 months from enrolment. This endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

Secondary

MeasureTime frameDescription
Percentage of falls associated to hospital admission at 12 months from enrolmentMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Severity of the fallMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Mortality attributable to fallMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Risk of falling at 12 months from enrolmentMonths 1 - Months 12This secondary endpoint will be calculated as the number of patients with at least one falls within 12 months from enrolment. This endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Total number of A&E accesses attributable to fallsMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Risk of A&E access attributable to fallsMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Length of stay as inpatient attributable to fallsMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls
Fall-free interval timeMonths 1 - Months 12This secondary endpoint will be recorded by participants in a fall diary (which will be collected from each participant at month 12). Recorded information in the fall diary will be monitored monthly with follow-up calls

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026